X-Chem, Inc.

📍 Waltham, United States🗓 Founded 2010👥 172 employees💰 Last funded 2016
Immense opportunities are within reach. X-Chem is the partner you need to unlock exponential possibilities in your small molecule drug discovery. We empower you to screen billions of compounds against your target with our groundbreaking DNA-encoded library (DEL) screening platform. No other partner understands DEL like X-Chem — our experts invented DEL-driven drug discovery and will help you leverage it with unprecedented speed and clarity. Small molecules hold exponential possibilities. Find your next candidate with X-Chem. We have demonstrated our success both internally and with external partnerships by tackling some of the most difficult, intractable targets such as: -protein:protein interactions (PPI) -antibacterial targets -ubiquitin ligases -epigenetic targets -GPCRs We have established collaborations with eight of the leading pharmaceutical companies in the world, including among others: Roche, AstraZeneca, Bayer and Pfizer. We also have partnerships with top tier biotechnology companies, academic centers and non-profit institutions. We have generated novel lead compounds against dozens of high-value therapeutic targets, leading to licensing of multiple lead series by our partners.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2010
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in X-Chem, Inc.?
X-Chem, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did X-Chem, Inc. last raise funding?
The most recent investment in X-Chem, Inc. recorded on gritt.io was in 2016.
When was X-Chem, Inc. founded?
X-Chem, Inc. was founded in 2010.
What industry is X-Chem, Inc. in?
X-Chem, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is X-Chem, Inc. based?
X-Chem, Inc. is headquartered in Waltham, United States.